The efficacy of prophylactic outpatient antibiotics for the prevention of neutropenic fever associated with high-dose etoposide (VP-16) for stem cell mobilization

Bone Marrow Transplantation

Volumn 30, Issue 5, 2002, Pages 311-314

  Avery, R K ^a   Pohlman, B L ^a   Mossad, S B ^a   Goormastic, M ^a   Longworth, D L ^a   Kalaycio, M E ^a   Sobecks, R M ^a   Andresen, S W ^a   Kuczkowski, E ^a   Bernhard, L ^a   Ostendorf, H ^a   Wise, K ^a   Bolwell, B J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Etoposide; Neutropenic fever; Stem cell mobilization

Indexed keywords

CEFEPIME; CIPROFLOXACIN; CLARITHROMYCIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; VANCOMYCIN; CEPHALOSPORIN DERIVATIVE;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; FEVER; HOSPITALIZATION; HUMAN; INCIDENCE; INFECTION; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; OUTPATIENT CARE; PRIORITY JOURNAL; STEM CELL MOBILIZATION; AMBULATORY CARE; CHEMICALLY INDUCED DISORDER; DRUG COMBINATION; INFORMATION PROCESSING; METHODOLOGY; MIDDLE AGED; OPPORTUNISTIC INFECTION;

AMBULATORY CARE; ANTIBIOTIC PROPHYLAXIS; CEPHALOSPORINS; CIPROFLOXACIN; CLARITHROMYCIN; DATA COLLECTION; DRUG THERAPY, COMBINATION; ETOPOSIDE; FEMALE; FEVER; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; MALE; MIDDLE AGED; NEUTROPENIA; OPPORTUNISTIC INFECTIONS; VANCOMYCIN;

EID: 0036739446     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703622     Document Type: Article

References (7)

1. O'Donnell LC, Elder PJ, Avalos BR. How many stem cells are sufficient for engraftment? In: Bolwell BJ (ed.). Current Controversies In Bone Marrow Transplantation. Humana Press: Totowa, 2000, pp 13-27.
2. Reiser M, Josting A, Draube A et al. Successful peripheral blood stem cell mobilization with etoposide (VP-16) in patients with relapsed or resistant lymphoma who failed cyclophosphamide mobilization. Bone Marrow Transplant 1999; 23: 1223-1228.
3. Kanfer EJ, McGuigan D, Samson D et al. High-dose etoposide with granulocyte colony-stimulating factor for mobilization of peripheral blood progenitor cells: efficacy and toxicity at three dose levels. Br J Cancer 1998; 78: 928-932.
4. Scheid C, Reiser M, Draube A et al. Mobilization with etoposide and granulocyte colony-stimulating factor can replace bone marrow harvesting in patients with malignant lymphoma who previously failed to mobilize sufficient stem cells with cyclophosphamide and G-CSF. J Hematother Stem Cell Res 2000; 9: 411-413.
5. Ashihara E, Shimazaki C, Okano A et al. Feasibility and efficacy of high-dose etoposide followed by low-dose G-CSF as a mobilization regimen in patients with non-Hodgkin's lymphoma. Haematologica 2000;85: 1112-1224.
6. Copelan EA, Ceselski SK, Ezzone SA et al. Mobilization of peripheral-blood progenitor cells with high-dose etoposide and granulocyte colony-stimulating factor in patients with breast cancer, non-Hodgkin's lymphoma, and Hodgkin's disease. J Clin Oncol 1997; 15: 759-765.
7. Hughes WT, Armstrong D, Bodey GP et al. 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America. Clin Infect Dis 1997; 25: 551-573.